Loading
companiesCompany
Founders Fund
Peter Thiel's San Francisco venture firm, best known for SpaceX, Palantir and Anduril. Its public portfolio page does not name any cancer companies, so its relevance to oncology is limited.
Overview
Founders Fund was founded in July 2005 by Peter Thiel, Ken Howery and Luke Nosek and is based at the Letterman Digital Arts Center in San Francisco (Wikipedia). It invests from seed to late stage in companies pursuing 'hard' technology and has historically been generalist, with occasional biotech investments. The portfolio page fetched lists SpaceX, Palantir, Anduril, Stripe, Neuralink, OpenAI and about 70 other companies; the only health-related names are Sword Health, Oscar and Cedar. No oncology company appears on the fetched page, so no portfolio examples are given here. Any cancer-related investments (for example, historical biotech holdings) would need to be sourced from a press release before being added.
Portfolio (1)
Filter the startups table| Company | Stage | Type | Cancers | Latest round |
|---|---|---|---|---|
| Ataraxis AI New York, NY, US | Startup | ai software | HR-positive / HER2-negative breast cancerHER2-positive breast cancerTriple-negative breast cancer (TNBC) | Series A 2025, $20M |
Notes
top- Website and Wikipedia verified, but no oncology portfolio company could be confirmed from a fetched page. Consider dropping from an oncology-specific graph.